Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.77 USD | +0.06% | -5.51% | -10.32% |
May. 09 | Earnings Flash (ACLX) ARCELLX Posts Q1 Revenue $39.3M | MT |
May. 09 | Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program | CI |
Financials (USD)
Sales 2024 * | 95.58M | Sales 2025 * | 104M | Capitalization | 2.66B |
---|---|---|---|---|---|
Net income 2024 * | -86M | Net income 2025 * | -122M | EV / Sales 2024 * | 20.2 x |
Net cash position 2024 * | 732M | Net cash position 2025 * | 548M | EV / Sales 2025 * | 20.4 x |
P/E ratio 2024 * |
-30.5
x | P/E ratio 2025 * |
-24.6
x | Employees | 130 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.3% |
1 day | +0.06% | ||
1 week | -5.51% | ||
Current month | -0.50% | ||
1 month | -14.29% | ||
3 months | -18.53% | ||
6 months | +9.38% | ||
Current year | -10.32% |
Managers | Title | Age | Since |
---|---|---|---|
Rami Elghandour
CEO | Chief Executive Officer | 45 | 21-01-21 |
Michelle Gilson
DFI | Director of Finance/CFO | 32 | 22-05-22 |
David Tice
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 20-07-31 |
Ali Behbahani
BRD | Director/Board Member | 47 | 15-01-31 |
Rami Elghandour
CEO | Chief Executive Officer | 45 | 21-01-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.01% | 746 M€ | -.--% | - | |
0.01% | 9 M€ | +9.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 49.77 | +0.06% | 587,871 |
24-05-10 | 49.74 | -5.67% | 925,475 |
24-05-09 | 52.73 | +0.92% | 377,239 |
24-05-08 | 52.25 | -0.32% | 545,473 |
24-05-07 | 52.42 | -0.47% | 311,293 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.32% | 2.66B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- ACLX Stock